China Pharma Holdings, Inc.CPHINYSE
Loading
Cost of Revenue Over TimeContracting
Percentile Rank0
3Y CAGR-20.1%
5Y CAGR-13.2%
Studio
Year-over-Year Change

Direct costs attributable to producing goods sold

3Y CAGR
-20.1%/yr
vs -4.5%/yr prior
5Y CAGR
-13.2%/yr
Recent deceleration
Acceleration
-15.5pp
Decelerating
Percentile
P0
Near historical low
vs 5Y Ago
0.5x
Contraction
Streak
4 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$4.39M-32.6%
2024$6.51M-10.7%
2023$7.29M-15.2%
2022$8.60M-7.5%
2021$9.29M+4.3%
2020$8.91M-5.6%
2019$9.44M-8.8%
2018$10.36M-3.6%
2017$10.74M-13.0%
2016$12.35M-